Impact of regulatory changes on the use of baclofen in alcohol use disorders between 2014 and 2021, using the French National Health Data System. [PDF]
Payet C +6 more
europepmc +1 more source
Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol-Related Hospitalizations: A Register Study. [PDF]
Bach P +5 more
europepmc +1 more source
Assessing Cravings Among Individuals with Alcohol Dependence Syndrome Prescribed with Anti-craving Medication: A Prospective Observational Study. [PDF]
Sultana M +4 more
europepmc +1 more source
Alcohol Use Disorder During Pregnancy: Harmonizing Multiple Datasets. [PDF]
Lessard C +8 more
europepmc +1 more source
The patterns of relapse and abstinence: using machine learning to identify a multidimensional signature of long-term outcome after inpatient alcohol withdrawal treatment. [PDF]
Raabe FJ +10 more
europepmc +1 more source
Things We Do for No Reason™: Avoiding naltrexone for alcohol use disorder in liver disease. [PDF]
Kee DP, Buyske JJ, Calcaterra SL.
europepmc +1 more source
Multi agent large language models for biomedical hypothesis generation in drug combination discovery. [PDF]
Xu Q +5 more
europepmc +1 more source
Impact of Multisite Patient Education on Pharmacotherapy for Veterans With Alcohol Use Disorder. [PDF]
Beauchamp JR +8 more
europepmc +1 more source
Investigating Therapeutic Targets for Alcohol Use Disorder: Pharmacological View of ClinicalTrials.gov Data. [PDF]
Alorfi NM.
europepmc +1 more source

